Shanrong Biotechnology Corp.
SRBT
$0.3216
-$0.3284-50.52%
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Revenue | 109.70K | 127.00K | 686.20K | 401.90K | 257.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 109.70K | 127.00K | 686.20K | 401.90K | 257.50K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 109.70K | 127.00K | 686.20K | 401.90K | 257.50K |
| SG&A Expenses | 4.07M | -107.60K | 1.04M | 1.09M | 1.11M |
| Depreciation & Amortization | 8.90K | 88.90K | 8.90K | 8.90K | 8.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.08M | -18.70K | 1.05M | 1.10M | 1.12M |
| Operating Income | -3.97M | 145.70K | -365.20K | -694.70K | -862.50K |
| Income Before Tax | -4.07M | 184.30K | -447.40K | -744.70K | -1.03M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.07M | 184.30K | -447.40K | -744.70K | -1.03M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.07M | 184.30K | -447.40K | -744.70K | -1.03M |
| EBIT | -3.97M | 145.70K | -365.20K | -694.70K | -862.50K |
| EBITDA | -3.97M | 154.60K | -356.30K | -685.80K | -853.60K |
| EPS Basic | -12.24 | 0.57 | -1.40 | -2.34 | -0.97 |
| Normalized Basic EPS | -7.65 | 0.36 | -0.87 | -1.46 | -0.61 |
| EPS Diluted | -12.51 | 0.57 | -1.40 | -2.34 | -1.11 |
| Normalized Diluted EPS | -7.65 | 0.36 | -0.87 | -1.46 | -0.61 |
| Average Basic Shares Outstanding | 332.60K | 321.10K | 320.30K | 318.00K | 1.06M |
| Average Diluted Shares Outstanding | 332.60K | 321.10K | 320.30K | 318.00K | 1.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
